Pfizer, Inc. Stock price

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:23 2024-03-18 pm EDT 5-day change 1st Jan Change
27.72 USD -0.79% Intraday chart for Pfizer, Inc. -2.29% -3.72%
Sales 2024 * 60.42B Sales 2025 * 63.09B Capitalization 157B
Net income 2024 * 7.89B Net income 2025 * 12.59B EV / Sales 2024 * 3.35 x
Net Debt 2024 * 45.61B Net Debt 2025 * 42.35B EV / Sales 2025 * 3.16 x
P/E ratio 2024 *
18.2 x
P/E ratio 2025 *
12.3 x
Employees 88,000
Yield 2024 *
6.13%
Yield 2025 *
6.29%
Free-Float 58.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.02%
1 week-2.29%
Current month+4.37%
1 month+0.36%
3 months+2.44%
6 months-17.60%
Current year-3.72%
More quotes
1 week
27.61
Extreme 27.61
28.69
1 month
25.61
Extreme 25.61
28.69
Current year
25.61
Extreme 25.61
30.28
1 year
25.61
Extreme 25.61
42.22
3 years
25.61
Extreme 25.61
61.71
5 years
25.61
Extreme 25.61
61.71
10 years
25.61
Extreme 25.61
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-03-18 27.72 -0.79% 36,226,501
24-03-15 27.94 -0.68% 75,727,854
24-03-14 28.13 -0.32% 36,427,957
24-03-13 28.22 +0.75% 39,272,983
24-03-12 28.01 -1.27% 48,758,226

Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
27.72 USD
Average target price
32.71 USD
Spread / Average Target
+18.02%
Consensus
  1. Stock
  2. Equities
  3. Stock Pfizer, Inc. - Nyse